{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-035727","form_type":"8-K","ticker":"CSBR","cik":"0000771856","company_name":"CHAMPIONS ONCOLOGY, INC.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.347719+00:00","generated_at":"2026-05-18T03:53:16.341182+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Champions Oncology reports record annual revenue $57M (+14%), net income $4.6M for FY2025","bullets":["Record annual revenue $57M, up 14% YoY; net income $4.6M vs loss of $7.4M prior year.","Adjusted EBITDA income $7.1M (vs loss of $3.9M); year-end cash $9.8M with no debt.","Q4 revenue $12.3M, down 12% YoY; Q4 adjusted EBITDA loss of $1.2M.","Data license revenue contributed $4.7M for fiscal year; new high-margin data business launched.","CEO cites return to growth and profitability; strong pipeline for FY2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-035727","json":"https://secwatch.observer/filing/0001628280-25-035727.json","markdown":"https://secwatch.observer/filing/0001628280-25-035727.md","text":"https://secwatch.observer/filing/0001628280-25-035727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/0001628280-25-035727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/csbr-20250723.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:53:16.341182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}